| Study Details | Efficacy, safety, and pharmacokinetics of vericiguat in pediatric participants with heart failure due to left ventricular systolic dysfunction |
| Protocol Number | 036-00 |
| Phase | II/III |
| Therapeutic Area | Heart failure |
| Subject Types | With Medical Condition |
| Indication | HF due to systemic LV Systolic Dysfunction |
| Principal Investigator | Dr Chen Ching Kit |
| Investigator Product / Device | MK-1242 |
| Sponsor |
Merck Sharp & Dohme LLC |
